fincash logo SOLUTIONS

Fincash » Search » Cadila Healthcare Ltd

Cadila Healthcare Ltd

Updated on October 15, 2020

Stock/Share Code - CADILAHC

Cadila Healthcare is one of the leading, innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovation (research & development), manufacturing, more

Below is the details of CADILAHC Cadila Healthcare Ltd

Market Cap₹38,006 Cr.
Current Price ₹426.35 as on 21 Oct 20
52 Week High / Low Price₹411.6 / ₹202
Face Value₹1
Stock P/E19.27
Book Value₹109.99
Dividend Yield0.94 %
ROCE13.76 %
ROE14.37 %
Sales Growth (3yrs)25.25 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has been maintaining a healthy dividend payout of 27.45%
Cons: Stock is trading at 3.37 times its book value Tax rate seems low Earnings include an other income of Rs.827.80 Cr. Debtor days have increased from 115.94 to 141.27 days.

Cadila Healthcare Ltd Price Chart

Cadila Healthcare Ltd Price Chart

Cadila Healthcare Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹169.4 28.81 ₹124,825.4 Cr. 0.77 -₹1,655.6 Cr. 24.82 -9.42 7585.25 10.53
2. Dr Reddy's Labs ₹5,046.75 36.47 ₹70,902.77 Cr. 0.59 ₹594.6 Cr. -12.11 14.73 4426.50 11.11
3. Cipla ₹767.1 34.95 ₹57,535.92 Cr. 0.42 ₹577.91 Cr. 20.85 8.95 4346.16 11.77
4. Aurobindo Pharma ₹806.2 15.87 ₹47,396.57 Cr. 0.37 ₹780.58 Cr. 20.99 8.82 5924.78 18.73
5. Biocon ₹439.6 70.21 ₹45,138 Cr. 0.13 ₹149.4 Cr. -27.58 14.56 1671.30 13.11
6. Torrent Pharma. ₹50.45 39.86 ₹45,039.6 Cr. 0.64 ₹321 Cr. 48.61 1.68 2056.00 15.01
7. Cadila Health. 19.27 ₹38,006.44 Cr. 0.94 ₹398.2 Cr. 405.97 33.64 1795.90 13.76
8. Alkem Lab ₹2,650.8 23.87 ₹32,553.96 Cr. 0.92 ₹422.01 Cr. 127.54 8.33 2003.49 18.58

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Cadila Healthcare Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -1,7381,5741,4551,5051,6441,6761,6681,3441,6831,8491,8121,796
YOY Sales Growth %138.58%107.52%77.41%44.33%-5.40%6.46%14.62%-10.71%2.32%10.33%8.66%33.64%
Expenses -1,0881,1491,0821,1211,1351,2191,2621,1611,2171,4331,2931,207
Material Cost %29.21%28.89%29.38%35.56%31.44%32.07%33.48%34.41%29.33%34.01%30.60%26.99%
Employee Cost %11.40%12.85%16.02%15.83%14.79%14.32%15.17%19.74%15.89%15.02%14.76%16.30%
Operating Profit650424373384509456406183466416520589
OPM %37%27%26%25%31%27%24%14%28%22%29%33%
Other Income6743461064105046274083936120
Profit before tax62338731536879143233894713322706478
Tax %28%21%23%16%16%16%23%16%12%12%12%17%
Net Profit45030624331066636326279628282619398
EPS in Rs4.392.992.363.036.513.552.560.776.132.755.923.89

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -1,6981,8332,9203,1513,5274,0425,2847,0323,2315,8106,0376,3477,139
Sales Growth %3.40%7.91%59.33%7.89%11.95%14.59%30.73%33.07%-54.06%79.83%3.92%5.13%
Expenses -1,5341,7992,2112,4832,8203,2333,7504,4542,9094,1644,4084,9625,149
Material Cost %38.26%41.90%29.79%32.91%35.93%35.01%31.25%26.90%31.22%29.19%30.88%30.75%
Manufacturing Cost %6.38%7.40%6.33%10.40%11.25%10.21%8.57%5.70%10.59%8.25%9.06%8.44%
Employee Cost %11.61%14.57%15.39%14.44%12.43%13.50%11.98%10.33%20.20%14.25%15.99%17.13%
Other Cost %34.08%34.30%24.22%21.05%20.34%21.27%19.16%20.41%28.03%19.97%17.07%21.87%
Operating Profit164347096687078091,5342,5783221,6461,6301,3851,990
OPM %10%2%24%21%20%20%29%37%10%28%27%22%28%
Other Income3036205723752307185174582208605895828
Profit before tax2965206376705319461,4652,5046421,4971,7871,6172,219
Tax %10%3%4%2%6%4%13%19%-3%27%17%13%
Net Profit2665036106584999041,2712,0386621,0911,4861,4131,927
EPS in Rs2.504.815.826.254.878.8211.9719.906.4510.6514.5113.8018.69
Dividend Payout %23%14%21%23%31%20%19%16%50%33%24%25%

Compounded Sales Growth

  • 10 Years:: 13.23%
  • 5 Years:: 3.73%
  • 3 Years:: 25.25%
  • TTM:: 12.76%

Compounded Profit Growth

  • 10 Years:: 10.64%
  • 5 Years:: 2.33%
  • 3 Years:: 29.08%
  • TTM:: 43.92%

Return on Equity

  • 10 Years:: 11.35%
  • 5 Years:: 0.15%
  • 3 Years:: -9.91%
  • 1 Year:: 64.75%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -6868102102102102102102102102102102
Equity Capital6868102102102102102102102102102102
Other Liabilities -5256558089128551,0271,3621,4241,4891,5461,5191,594
Trade Payables278374346285361462671900996803701863
Advance from Customers3447810208673530
Other liability items243276458620486556672516488735782702
Total Liabilities2,5772,8713,4624,7545,5526,2437,3378,92311,04712,16413,67116,552
Fixed Assets -8379501,0371,2181,4971,5641,7682,1552,3522,6803,9324,109
Gross Block1,3581,5571,7322,0162,5112,6843,1193,7203,8964,5166,1526,564
Accumulated Depreciation5025866767981,0141,1201,3511,5661,5441,8362,2202,455
Other Assets -1,0281,1791,4932,0122,3112,5912,9934,1544,0935,2064,8685,486
Trade receivables3524014756166837221,0561,7079291,2552,1122,457
Cash Equivalents262842118928912916417184112385
Loans n Advances334402210272305378331294404865684648
Other asset items-33-333015056457376731,3321,8101,582487601
Total Assets2,5772,8713,4624,7545,5526,2437,3378,92311,04712,16413,67116,552

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -2685865603724458781,0841,9548672885811,182
Profit from operations3916227346236668641,5762,6503051,6971,7451,727
Loans Advances00-38-61-28-321300000
Other WC items00-15094-114-10191756-375211-133
Working capital changes-7-40-111-230-161-34-236-279670-1,114-852-343
Interest paid-5500000000000
Direct taxes-23-26-63-23-6822-197-414-112-295-312-202
Other operating items000-6826-6000000
Exceptional CF items-382908000-24001
Cash from Investing Activity --267-249-368-817-709-408-577-1,016-2,48028-71355
Fixed assets purchased-175-232-303-378-542-282-304-573-777-602-725-597
Fixed assets sold24218523224355
Investments purchased-152-53-100-706-136-285-388-154-1,5560-140
Investments sold134019702101657103398
Interest received074151122276383102373
Dividends received40365221134272140040150387742
Loans to subsidiaries0-102-40-162-134-285-56-414-1,631-227-186-95
Acquisition of companies000000000-360-1,373-11
Other investing items-6602056124342992353817-0
Cash from Financing Activity -6-335-178522250-446-387-9231,366-14965-969
Proceeds from borrowings72219678836933293041011,929320677249
Repayment of borrowings0-444-97-162-194-529-440-328-212-416-171-361
Interest paid fin0-38-33-56-74-73-39-18-22-53-82-140
Dividends paid-56-62-102-128-153-153-184-573-3270-358-717
Other financing items-10-10-12-15-22-20-27-106-20-1-1
Net Cash Flow731476-142512014-247167-67268

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %20%27%28%24%15%20%27%38%8%15%16%14%
Debtor Days768059717165738910579128141
Inventory Turnover2.

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Cadila Healthcare Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.